Pharmacoeconomic analysis of various treatment regimens of Congo-Crimean hemorrhagic fever
G. Abuova, N. Pshenichnaya, L. Ermakova and 5 more
International Journal of Infectious Diseases · 2020
doi:10.1016/j.ijid.2020.09.1367 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: Kazakhstan has gained experience in the treatment of Congo-Crimean hemorrhagic fever (CCHF) with ribavirin and immunized plasma. In recent years, the effectiveness of therapy in various diseases has been evaluated not only by clinical and laboratory parameters, but also by pharmacoeconomic indicators.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.